Browse by author
Lookup NU author(s): Professor Dorothy Newbury-Birch, Dr Colin Muirhead, Dr Eilish Gilvarry, Professor Vera Araujo-SoaresORCiD, Professor Nick ReynoldsORCiD, Professor Eileen KanerORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2017 British Association of Dermatologists. Background: There is a known association between psoriasis and heavy alcohol consumption. The association between heavy alcohol consumption and other inflammatory skin diseases remains to be defined. Objectives: To examine the prevalence of heavy drinking using the Alcohol Use Disorders Identification Test (AUDIT) in patients with inflammatory skin disease. Methods: We conducted an observational cross-sectional study in a single hospital outpatient department. We recruited 609 patients with either psoriasis, eczema, cutaneous lupus or other inflammatory disorders, and a reference population with skin lesions. Primary outcome was the proportion of patients in each group with an alcohol use disorder (AUD). Results: The observed prevalence of AUD was 30·6% in patients with psoriasis, 33·3% in those with eczema, 12·3% in those with cutaneous lupus, 21·8% in those with other inflammatory disease and 14·3% in those with non-inflammatory disease. Odds ratios (OR) for AUD in patients in the inflammatory groups compared with those in the noninflammatory groups, adjusted for age and sex, were as follows: psoriasis 1·65 [95% confidence interval (CI) 0·86-3·17], eczema 2·00 (95% CI 1·03-3·85), lupus 1·03 (95% CI 0·39-2·71), other inflammatory disease 1·32 (95% CI 0·68-2·56). ORs were reduced if also adjusted for Dermatology Life Quality Index (DLQI). The prevalence of DLQI ≥ 11 was 31·1% for psoriasis, 43·7% for eczema, 17·5% for cutaneous lupus, 17·2% for other inflammatory disease and 2·8% for noninflammatory disease. Conclusions: Patients with eczema attending a hospital clinic have been shown to have high levels of AUD of a similar level to patients with psoriasis and higher than patients with noninflammatory skin diseases.
Author(s): Al-Jefri K, Newbury-Birch D, Muirhead CR, Gilvarry E, Araujo-Soares V, Reynolds NJ, Kaner E, Hampton PJ
Publication type: Article
Publication status: Published
Journal: British Journal of Dermatology
Year: 2017
Volume: 177
Issue: 3
Pages: 837-844
Print publication date: 22/09/2017
Online publication date: 07/07/2017
Acceptance date: 20/03/2017
ISSN (print): 0007-0963
ISSN (electronic): 1365-2133
Publisher: Wiley-Blackwell
URL: https://doi.org/10.1111/bjd.15497
DOI: 10.1111/bjd.15497
Altmetrics provided by Altmetric
